Marshall Wace’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $287K | Sell |
35,352
-32,468
| -48% | -$264K | ﹤0.01% | 2203 |
|
|
2025
Q1 | $477K | Sell |
67,820
-65,371
| -49% | -$460K | ﹤0.01% | 1983 |
|
|
2024
Q4 | $990K | Sell |
133,191
-67,509
| -34% | -$502K | ﹤0.01% | 1623 |
|
|
2024
Q3 | $989K | Sell |
200,700
-99,420
| -33% | -$490K | ﹤0.01% | 1526 |
|
|
2024
Q2 | $1.54M | Buy |
300,120
+139,887
| +87% | +$718K | ﹤0.01% | 1350 |
|
|
2024
Q1 | $851K | Buy |
160,233
+16,340
| +11% | +$86.8K | ﹤0.01% | 1503 |
|
|
2023
Q4 | $891K | Buy |
143,893
+54,263
| +61% | +$336K | ﹤0.01% | 1251 |
|
|
2023
Q3 | $676K | Sell |
89,630
-37,437
| -29% | -$282K | ﹤0.01% | 1365 |
|
|
2023
Q2 | $1.23M | Buy |
+127,067
| New | +$1.23M | ﹤0.01% | 1306 |
|
|
2022
Q1 | – | Sell |
-104
| Closed | -$1K | – | 2979 |
|
|
2021
Q4 | $1K | Buy |
+104
| New | +$1K | ﹤0.01% | 3085 |
|